Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85

Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66

NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol (2011) 3.28

The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis (2010) 2.96

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol (2013) 2.92

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer (2009) 2.19

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology (2012) 2.10

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer (2010) 2.04

Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study. BMJ (2010) 2.01

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics (2011) 1.81

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology (2014) 1.75

Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol (2009) 1.68

Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol (2008) 1.68

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med (2014) 1.64

Non-viral causes of hepatocellular carcinoma. World J Gastroenterol (2010) 1.63

Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol (2007) 1.59

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol (2005) 1.54

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2011) 1.46

Role of free radicals in liver diseases. Hepatol Int (2009) 1.36

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol (2010) 1.34

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol (2009) 1.33

Liver diseases and metabolic syndrome. J Gastroenterol (2008) 1.33

The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther (2006) 1.27

Targeted therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol (2009) 1.27

Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol (2006) 1.25

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Gut Liver (2015) 1.23

2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol (2015) 1.14

Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol (2008) 1.13

Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol (2014) 1.12

Non-alcoholic fatty liver disease: The diagnosis and management. World J Hepatol (2015) 1.11

Liver and diabetes. A vicious circle. Hepatol Res (2013) 1.10

Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer (2012) 1.09

The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One (2011) 1.08

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey. J Gastroenterol (2011) 1.06

Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Br J Cancer (2013) 1.03

Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol (2010) 1.02

Cancer risk in HBV patients with statin and metformin use: a population-based cohort study. Medicine (Baltimore) (2015) 1.02

AEG-1/MTDH/LYRIC in liver cancer. Adv Cancer Res (2013) 1.01

Primary hepatocellular carcinoma and metabolic syndrome: An update. World J Gastrointest Oncol (2013) 1.00

Nonalcoholic fatty liver disease and hepatocellular carcinoma. Biomed Res Int (2014) 0.97

Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. World J Gastroenterol (2014) 0.97

Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization. World J Gastroenterol (2010) 0.97

Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma. Oncologist (2012) 0.97

Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality. Cancer Epidemiol Biomarkers Prev (2013) 0.96

Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis. Int J Mol Sci (2012) 0.95

Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005. Br J Cancer (2009) 0.95

Risk of liver cancer among US male veterans with cirrhosis, 1969-1996. Br J Cancer (2012) 0.94

Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol (2013) 0.94

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol (2014) 0.93

Non-viral factors contributing to hepatocellular carcinoma. World J Hepatol (2013) 0.93

Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. J Diabetes Complications (2013) 0.93

Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician (2007) 0.93

Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan. BMC Cancer (2014) 0.93

[Hepatocellular carcinoma in the non-cirrhotic liver]. Pathologe (2008) 0.92

Hepatic steatosis: a benign disease or a silent killer. World J Gastroenterol (2008) 0.92

Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma. Acta Pharmacol Sin (2010) 0.92

HBV induced HCC: major risk factors from genetic to molecular level. Biomed Res Int (2013) 0.92

First multicenter study for risk factors for hepatocellular carcinoma development in North Africa. World J Hepatol (2011) 0.92

Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma. Hepatology (2013) 0.91

Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis. Semin Immunopathol (2012) 0.90

Progression of liver cirrhosis to HCC: an application of hidden Markov model. BMC Med Res Methodol (2011) 0.90

Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World J Gastroenterol (2013) 0.90

Hepatitis C virus induced insulin resistance impairs response to anti viral therapy. World J Gastroenterol (2012) 0.90

The molecular pathogenesis and clinical implications of hepatocellular carcinoma. Int J Hepatol (2011) 0.89

Molecular therapies in hepatocellular carcinoma: what can we target? Dig Dis Sci (2014) 0.89

Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice. BMC Cancer (2011) 0.89

Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus. J Gastroenterol (2009) 0.89

Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol (2010) 0.89

Development of Wistar rat model of insulin resistance. World J Gastroenterol (2005) 0.89

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study. BMC Cancer (2012) 0.89

The interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C. Can J Gastroenterol (2012) 0.88

Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study. Nutr J (2011) 0.88

The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci (2016) 0.88

Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy. J Gastroenterol (2011) 0.87

Interaction between hepatitis C virus and metabolic factors. World J Gastroenterol (2014) 0.87

Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area. PLoS One (2013) 0.86

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort. Carcinogenesis (2011) 0.86

Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question. World J Gastroenterol (2015) 0.86

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. Int J Mol Sci (2016) 0.86

Hepatocellular carcinoma in Asia: Prevention strategy and planning. World J Hepatol (2015) 0.85

Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance. Gut Liver (2009) 0.85

A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: controlled by ATF3. Cell Signal (2009) 0.85

Hepatitis C virus infection and nonalcoholic steatohepatitis. Gastroenterol Hepatol (N Y) (2012) 0.84

Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma. Clin Liver Dis (2011) 0.84

Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD. Dig Dis Sci (2016) 0.84

Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma. Mayo Clin Proc (2012) 0.84

Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis. Hum Vaccin Immunother (2015) 0.84

Viral genotypes and associated risk factors of hepatocellular carcinoma in India. Cancer Biol Med (2012) 0.84

hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among East Asians: a meta-analysis. PLoS One (2013) 0.83

Recent trends in hepatectomy for elderly patients with hepatocellular carcinoma. Surg Today (2013) 0.83

Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy. Dig Dis Sci (2016) 0.83

Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats. J Gastroenterol (2009) 0.83

Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment. J Clin Biochem Nutr (2011) 0.83

Evolving therapies in the treatment of hepatocellular carcinoma. Biologics (2008) 0.83

Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol (2013) 0.83

Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. World J Gastroenterol (2013) 0.82

The Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know. J Clin Imaging Sci (2015) 0.82

Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges? World J Hepatol (2014) 0.82

Hepatocellular carcinoma: HCC. Hepat Mon (2011) 0.82

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med (2008) 9.33

A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73

The burden of selected digestive diseases in the United States. Gastroenterology (2002) 6.79

Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr (2008) 5.01

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology (2003) 4.95

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology (2009) 4.90

The prevalence of celiac disease in the United States. Am J Gastroenterol (2012) 4.77

Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology (2004) 4.27

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology (2009) 3.50

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials (2004) 3.46

Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology (2005) 3.12

Relationship of hepatitis C virus infection with diabetes in the U.S. population. Hepatology (2014) 3.04

Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72

Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology (2002) 2.64

Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol (2005) 2.63

Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology (2008) 2.63

Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population. Clin Gastroenterol Hepatol (2005) 2.51

Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology (2010) 2.47

The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc (2006) 2.43

Obesity increases oesophageal acid exposure. Gut (2006) 2.42

A survey of liver transplantation from living adult donors in the United States. N Engl J Med (2003) 2.37

Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30

Activity energy expenditure and incident cognitive impairment in older adults. Arch Intern Med (2011) 2.07

Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med (2007) 2.07

Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. J Med Virol (2005) 2.04

Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis (2011) 2.03

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. Hepatology (2011) 1.98

Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol (2013) 1.95

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology (2005) 1.93

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin. Hepatology (2003) 1.87

Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort. J Natl Cancer Inst (2010) 1.81

Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology (2005) 1.76

Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. Clin Gastroenterol Hepatol (2007) 1.71

Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology (2010) 1.70

Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Gastroenterology (2010) 1.67

Epidemiology of nonalcoholic fatty liver. Clin Liver Dis (2004) 1.59

Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2011) 1.59

A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med (2003) 1.58

Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology (2010) 1.52

Energy requirements in the eighth decade of life. Am J Clin Nutr (2004) 1.46

Risk factors for inguinal hernia among adults in the US population. Am J Epidemiol (2007) 1.45

Anthropometric correlates of intragastric pressure. Scand J Gastroenterol (2006) 1.43

Diabetes increases the risk of acute hepatic failure. Gastroenterology (2002) 1.39

Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology (2009) 1.35

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Hepatology (2011) 1.33

Gallstone disease is associated with increased mortality in the United States. Gastroenterology (2010) 1.32

Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One (2009) 1.32

Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31

Water turnover in 458 American adults 40-79 yr of age. Am J Physiol Renal Physiol (2003) 1.24

Body composition data for individuals 8 years of age and older: U.S. population, 1999-2004. Vital Health Stat 11 (2010) 1.24

High proportion of influenza B characterises the 2008 influenza season in Victoria. Commun Dis Intell Q Rep (2009) 1.22

A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology (2013) 1.21

Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology (2003) 1.19

Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology (2009) 1.18

Influence of delayed isotopic equilibration in urine on the accuracy of the (2)H(2)(18)O method in the elderly. J Appl Physiol (1985) (2002) 1.15

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology (2006) 1.13

Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg (2010) 1.13

Serum leptin concentrations and body adipose measures in older black and white adults. Am J Clin Nutr (2004) 1.10

Upper limits of normal for alanine aminotransferase activity in the United States population. Hepatology (2012) 1.10

Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res (2002) 1.10

Activity energy expenditure and change in body composition in late life. Am J Clin Nutr (2009) 1.09

Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies. J Infect Dis (2014) 1.07

An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C. PLoS One (2011) 1.04

Body mass index and serum leptin concentration independently estimate percentage body fat in older adults. Am J Clin Nutr (2007) 1.03

Activity energy expenditure and mobility limitation in older adults: differential associations by sex. Am J Epidemiol (2009) 1.02

Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C. Gastroenterology (2011) 1.02

The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol (2004) 1.02

Modifiable environmental and behavioral determinants of overweight among children and adolescents: report of a workshop. Obesity (Silver Spring) (2006) 0.98

Hyperlipasemia associated with hepatitis C virus. Dig Dis Sci (2003) 0.97

Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology (2010) 0.96

Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. Vaccine (2011) 0.94

Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C. Hepatology (2008) 0.91

Chikungunya virus infection in traveler to Australia. Emerg Infect Dis (2007) 0.91

Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium. Liver Transpl (2013) 0.91

Physical activity and gallbladder disease determined by ultrasonography. Med Sci Sports Exerc (2007) 0.90

Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2014) 0.89

Reality check of laboratory service effectiveness during pandemic (H1N1) 2009, Victoria, Australia. Emerg Infect Dis (2011) 0.88

Fatty liver: think globally. Hepatology (2010) 0.87

The concurrent validity of a hand-held versus a stationary dynamometer in testing isometric shoulder strength. J Hand Ther (2009) 0.85

Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains. Hepatology (2003) 0.84

Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology (2008) 0.84

Laboratory diagnosis, molecular characteristics, epidemiological and clinical features of an outbreak of measles in a low incidence population in Australia. J Clin Virol (2012) 0.82

Contact tracing of in-flight measles exposures: lessons from an outbreak investigation and case series, Australia, 2010. Western Pac Surveill Response J (2011) 0.81

Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Liver Transpl (2013) 0.81

Longitudinal change in energy expenditure and effects on energy requirements of the elderly. Nutr J (2013) 0.80

Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7). Pharmacogenet Genomics (2011) 0.80

The association of low serum alanine aminotransferase activity with mortality in the US population. Am J Epidemiol (2013) 0.80

Epidemiologic research and the action plan for liver disease research. Ann Epidemiol (2006) 0.79

Is cirrhosis an inevitable consequence of chronic hepatitis C virus infection? Clin Gastroenterol Hepatol (2005) 0.78

Evaluation of swabs, transport media, and specimen transport conditions for optimal detection of viruses by PCR. J Clin Microbiol (2012) 0.78

The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study. Eur J Epidemiol (2013) 0.78

Measles with a possible 23 day incubation period. Commun Dis Intell Q Rep (2012) 0.78

Higher than normal seasonal influenza activity in Victoria, 2003. Commun Dis Intell Q Rep (2004) 0.77

A prospective study of dyspepsia in primary care. Dig Dis Sci (2002) 0.77

Diurnal variation in serum alanine aminotransferase activity in the US population. J Clin Gastroenterol (2013) 0.76

Alcohol and hepatitis C: do we have a drinking problem? Gastroenterology (2006) 0.75

Non-alcoholic fatty liver disease (NAFLD) and mortality. J Hepatol (2009) 0.75